Industry reports
Editor highlights

The Global OTC Pharmaceutical Market 2010-2025

Visiongain
  • Publication date: July 2010
  • Report price: $ 2 313

Get this report today!

$ 2 313 - 1 User License
$ 4 627 - Department License
$ 7 713 - Site License
$ 10 798 - Corporate License

Summary

Table of Contents

Data Series


Report Details – where will opportunities lie in this diverse market with growing demand worldwide?

In 2009, the global over-the-counter (OTC) pharmaceutical market generated revenues of more than $60bn. Our analyses show that total OTC revenues will exceed $70bn by 2015. From 2010 onwards, Rx-to-OTC switching and the continuing importance of emerging healthcare markets will drive sales in this sector. Our forecasts reveal that the OTC pharma market will grow significantly from 2010 onwards. This report explains where future OTC switching and other developments will occur, providing you with the information that you need to understand the current OTC market and its future prospects.

Our new report – The Global OTC Pharmaceutical Market 2010-2025 – explains how this market will develop, and where the opportunities will lie. We show how you can benefit from its developments and potential. That study examines all the prominent OTC pharmaceutical categories, including:
• Cough, cold and allergy medications
• Analgesics
• Gastrointestinal drugs
• Dermatological preparations
• Smoking-cessation aids
• Others – including contraceptives, anti-obesity treatments, statins and erectile dysfunction treatments.

What types of OTC medications are likely to enter the market from 2010 onwards, and what will their sales potential be like? Where will the main opportunities lie, and what are the drivers and restraints in this market sector? Our study will provide you with up-to-date information that you need to understand current trends and future directions in the market.

Comprehensive analysis of the global OTC pharmaceutical industry and market

The Global OTC Pharmaceutical Market 2010-2025 examines that sector through a comprehensive review of information sources. We harness primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of Rx-OTC switching developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 90 tables and figures included, as well as an expert interview. The result is an extensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy The Global OTC Pharmaceutical Market 2010-2025

This report gives you the following benefits in particular:
• You will assess the current OTC pharmaceutical market
• You will receive a forecast for the overall OTC pharmaceutical market from 2010 to 2025, with global revenues and supporting discussions
• You will view revenue forecasts for the leading OTC pharmaceutical categories from 2010 to 2025, with discussions of market potential and competition
• You will view revenue forecasts for the leading companies in the OTC sector from 2010 to 2015, with discussions and other supporting information
• You will view revenue forecasts from 2010 to 2025 for leading products in this market, with discussions of market potential and competition
• You will receive OTC revenue forecasts for leading national markets from 2010 to 2025, with supporting discussions
• You will analyse the drivers, restraints, competition and opportunities influencing the market for OTC pharmaceuticals from 2010 onwards
• You will receive coverage of OTC switching from 2010 onwards, highlighting important developments likely to occur
• You will discover expert views on that industry/market sector, including a full interview transcript.

You can obtain this report today

Our new report is essential reading for everybody interested in the OTC pharmaceutical industry and market. We predict that total revenues will increase during our forecast period. High costs of prescription drugs combined with strained healthcare budgets and high, rising prevalence of the many conditions treated by OTC medications will drive market growth. Do you want to harness the opportunities in this market area? You can stay ahead by ordering our report today.

Visiongain
  • Publication date: July 2010
  • Report price: $ 2 313

Get this report today!

$ 2 313 - 1 User License
$ 4 627 - Department License
$ 7 713 - Site License
$ 10 798 - Corporate License

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Global Pharmaceutical Industry : Latest Reports

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • December 2013
  • by Global Data

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) - diabetic nephropathy, ...

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 9 995
  • Industry report
  • January 2014
  • by Global Data

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Global Pharmaceutical Industry : Latest Downloads

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...

Drug and Medication Market Brief

  • Industry report
  • March 2014
  • 17 pages

... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...

Drug Discovery and Development Industry Brief

  • Industry report
  • March 2014
  • 47 pages
  • by Research Paper

... Learn/confirm and predict phase vi registering and labeling (maa) uncertainty confident and drug and disease paediatric strategy & investigation plan scientific advice clinical trial ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.